✦ LIBER ✦

P439 In patients with Crohn's disease, timing of switching from infliximab to adalimumab affects prognosis

✍ Scribed by Takeuchi, K.; Yamada, A.; Suzuki, Y.

Book ID: 122164892
Publisher: Oxford University Press
Year: 2014
Tongue: English
Weight: 50 KB
Volume: 8
Category: Article
ISSN: 1873-9946
DOI: 10.1016/S1873-9946(14)60559-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Su1127 In Patients With Crohn's Disease,

Su1127 In Patients With Crohn's Disease, Timing of Switching From Infliximab Maintenance Therapy to Adalimumab Affects Patients' Prognosis

✍ Takeuchi, Ken; Yamada, Akihiro; Suzuki, Yasuo 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 211 KB

P495 Efficacy of switching to infliximab

P495 Efficacy of switching to infliximab in Crohn's disease patients with loss of response to adalimumab

✍ Peeters, H.; Louis, E.; Baert, F.; Dewit, O.; Coche, J.-C.; Ferrante, M.; Lambre 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 50 KB

Switch to adalimumab in patients with Cr

Switch to adalimumab in patients with Crohn's disease controlled by maintenance infliximab: prospective randomised SWITCH trial

✍ Van Assche, G.; Vermeire, S.; Ballet, V.; Gabriels, F.; Noman, M.; D'Haens, G.; 📂 Article 📅 2011 🏛 BMJ Publishing Group 🌐 English ⚖ 356 KB

Switch to adalimumab in patients with Cr

Switch to adalimumab in patients with Crohn's disease controlled by maintenance infliximab: prospective randomised SWITCH trial

✍ Van Assche, G.; Vermeire, S.; Ballet, V.; Gabriels, F.; Noman, M.; D'Haens, G.; 📂 Article 📅 2011 🏛 BMJ Publishing Group 🌐 English ⚖ 356 KB

## Background: Elective switching between anti-tumour necrosis factor (tnf) agents not necessarily dictated by efficacy or tolerability occurs in clinical practice. a study was undertaken to evaluate prospectively the impact of elective switching of patients with crohn's disease well controlled wit

Sa1275 Clinical Impact of Evaluating Sui

Sa1275 Clinical Impact of Evaluating Suitable Timing for Switching From Infliximab to Adalimumab According to Precise Endoscopic Monitoring in Patients With Crohn's Disease

✍ Kamata, Noriko; Watanabe, Kenji; Morimoto, Kenichi; Noguchi, Atsushi; Miyazaki, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 128 KB

645 Switch to Adalimumab in Patients Wit

645 Switch to Adalimumab in Patients With Crohn's Disease Controlled by Maintenance Infliximab. the Prospective Randomized Switch Study

✍ Gert A. Van Assche; Severine Vermeire; Vera Ballet; Maja Noman; Geert R. D'Haens 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 52 KB